Drugs@FDA document
SIVEXTRO Letter · NDA 205435 SUPPL-10
Drugs@FDA document · CUBIST PHARMS LLC · Mar 8, 2019
Key facts
| Drug name | SIVEXTRO |
|---|---|
| Document type | Letter |
| Application | NDA205435 |
| Submission | SUPPL-10 |
| Company | CUBIST PHARMS LLC |
| Document date | Mar 8, 2019 |
At a glance
- Efficacy-Labeling Change With Clinical Data Document categories
- 10–99 Documents for this application
- 10–99 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: